Cardiac troponin I: Prothrombotic risk marker in non-valvular atrial fibrillation

International Journal of Cardiology

Volumn 167, Issue 3, 2013, Pages 877-882

  Providência, Rui ^a,b   Paiva, Luís ^a   Faustino, Ana ^a   Botelho, Ana ^a   Trigo, Joana ^a   Casalta Lopes, João ^c   Nascimento, José ^a   Leitão Marques, António Manuel ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Atrial fibrillation; Biomarkers; Cardiac troponin I; Stroke; Thromboembolism

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I;

ADULT; AGED; AORTA ATHEROSCLEROSIS; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHA2DS2VASC SCORE; CHADS2 SCORE; CONGESTIVE HEART FAILURE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FLOW RATE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; INDEXED LEFT ATRIAL VOLUME; INDEXED LEFT VENTRICLE DIASTOLIC DIAMETER; LABORATORY TEST; LEFT ATRIAL APPENDAGE THROMBUS; MAJOR CLINICAL STUDY; MALE; NET RECLASSIFICATION IMPROVEMENT; NON VALVULAR ATRIAL FIBRILLATION; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY ANALYSIS; THROMBOEMBOLISM; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ATRIAL FIBRILLATION; BIOMARKERS; CARDIAC TROPONIN I; STROKE; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; THROMBOEMBOLISM; TROPONIN I;

EID: 84880917627     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.093     Document Type: Article

References (22)

1. J.J. Brugts, S. Akin, A.M. Helming, S. Loonstra, E.J. van den Bos, and M.J. Kofflard The predictive value of cardiac biomarkers in prognosis and risk stratification of patients with atrial fibrillation Curr Opin Cardiol 26 5 2011 Sep 449 456
2. I.A. Khan, A. Tun, and N. Wattanasauwan Elevation of serum cardiac troponin I in noncardiac and cardiac diseases other than acute coronary syndromes Am J Emerg Med 17 1999 225 229
3. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, and A.J. Camm Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 10 Oct. 2010 1360 1420
4. L.S. Wann, A.B. Curtis, and C.T. January 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Heart Rhythm 8 1 Jan. 2011 157 176
5. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of atrial fibrillation JAMA 285 2001 2864 2870
6. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
7. M. Zabalgoitia, J.L. Halperin, L.A. Pearce, J.L. Blackshear, R.W. Asinger, and R.G. Hart Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke prevention in atrial fibrillation III investigators J Am Coll Cardiol 31 1998 1622 1626
8. D.Y. Leung, I.W. Black, G.B. Cranney, A.P. Hopkins, and W.F. Walsh Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation J Am Coll Cardiol 24 1994 755 762
9. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation Ann Intern Med 128 1998 639 647
10. L.P. Badano, N. Pezzutto, and R. Marinigh How many patients would be misclassified using M-mode and two-dimensional estimates of left atrial size instead of left atrial volume? A three-dimensional echocardiographic study J Cardiovasc Med (Hagerstown) 9 5 2008 May 476 484
11. C. Russo, R.T. Hahn, Z. Jin, S. Homma, R.L. Sacco, and M.R. Di Tullio Comparison of echocardiographic single-plane versus biplane method in the assessment of left atrial volume and validation by real time three-dimensional echocardiography J Am Soc Echocardiogr 23 9 2010 Sep 954 960
12. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
13. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification Eur J Echocardiogr 7 2006 79 108
14. D. Fatkin, R.P. Kelly, and M.P. Feneley Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo J Am Coll Cardiol 23 1994 961 969
15. P. Amarenco, A. Cohen, and C. Tzourio Atherosclerotic disease of the aortic arch and the risk of ischemic stroke N Engl J Med 331 22 1994 Dec 1 1474 1479
16. M. Pencina, R. D'Agostino, R.B. D'Agostino Jr., and R. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
17. J.B. Olesen, G.Y. Lip, and M.L. Hansen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 Jan. 31 2011 d124
18. S. Ederhy, E. Di Angelantonio, G. Dufaitre, C. Meuleman, J. Masliah, L. Boyer-Chatenet, F. Boccara, and A. Cohen C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation Int J Cardiol 159 1 2012 40 46
19. R. Providência, A. Botelho, J. Trigo, N. Quintal, J. Nascimento, P. Mota, and A. Leitão-Marques Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters Europace 14 1 2012 36 45
20. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 12 Sep. 17 2009 1139 1151
21. Z. Hijazi, J. Oldgren, and U. Anderson Troponin I elevation increases the risk of death and stroke in patients with atrial fibrillation - a RE-LY substudy Eur Heart J 31 2010 886 [Abstract Supplement]
22. Z. Hijazi, J. Oldgren, and U. Andersson NT-proBNP is prognostic for stroke and death in atrial fibrillation - a RELY Substudy Circulation 122 2010 A13472